About Polfa Tarchomin
Polfa Tarchomin is a company based in Warsaw (Poland) founded in 1823. It operates as a B2B and B2C. Polfa Tarchomin offers products and services including Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and GOLDisept. Polfa Tarchomin operates in a competitive market with competitors including AmerisourceBergen, NEUCA, Pelion and Vitama, among others.
- Headquarter Warsaw, Poland
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website polfa-tarchomin.com.pl
- Legal Name Tarchomińskie Zakłady Farmaceutyczne "Polfa" Spółka Akcyjna
Products & Services of Polfa Tarchomin
Polfa Tarchomin offers a comprehensive portfolio of products and services, including Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and GOLDisept.
Topical treatment for skin conditions and inflammation.
Medication for fungal infections in various forms.
Natural supplement for cholesterol management.
Probiotic blend for digestive health support.
Spray for throat relief and hygiene.
Moisturizing cream with protective ingredients.
People of Polfa Tarchomin
11 people are tracked at Polfa Tarchomin (8 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Rafał Łunio | Director Of Research & Development; Qualified Person (qp) | Leadership |
Katarzyna Nędzi | Head Of Strategic Project Management Office | Leadership |
Maksymilian Świniarski | CEO | Leadership |
Magdalena Skrzypczyńska | Head Of Marketing | Leadership |
Ania Miller | Head Of Business Excellence | Leadership |
Małgorzata Stokrocka | R&d; Bd; Quality Director, Proxy, QP | Leadership |
Tomasz Grzywnowicz | Marketing And Sales Director / Digital/ PR /business Effectivens Director At TZF Polfa | Leadership |
Marlena Dryżałowska | R&d Project Management Director | Leadership |
Agnieszka Woźniak | R&d Project Manager | Team |
Sami al Bitar Nehmé | Formulation Scientist | Team |
Piotr Sikorski | Technolog | Team |
Complete people profiles for Polfa Tarchomin
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Polfa Tarchomin
Polfa Tarchomin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, NEUCA, Pelion and Vitama, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| pelion.eu | 1990 | Lodz, Poland | – | – | Pelion is recognized as a leading healthcare company in Poland. | |
| vitama.pl | 2012 | Warsaw, Poland | – | – | Pharmaceutical products are distributed by Vitama in Poland. |
Detailed competitors of Polfa Tarchomin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Polfa Tarchomin
The website of Polfa Tarchomin (polfa-tarchomin.com.pl) receives about 1.1K visits a month and ranks #3,100,911 among all websites worldwide, #4,099 in Biotechnology and Pharmaceuticals.
- Monthly visits1.1K
▼ 79.8% vs previous month
- Unique visitors2.9K
per month
- Global rank#3,100,911
among all websites
- Category rank#4,099
Health · Biotechnology and Pharmaceuticals
- Bounce rate52%
- Pages per visit2.2
- Average visit40 sec
- DevicesDesktop 25% · Mobile 75%
Websites whose visitors overlap most with Polfa Tarchomin. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| polfawarszawa.pl | 100% | – | – | View details | |
| polpharma.pl | 74% | 28.1K | #1,405,803 | View details |
Latest news on Polfa Tarchomin
Complete news archive for Polfa Tarchomin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Polfa Tarchomin
10 companies that operate in the same segment as Polfa Tarchomin (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Polfa Tarchomin
Polfa Tarchomin was founded in 1823.
Polfa Tarchomin is headquartered in Warsaw, Poland.
Polfa Tarchomin, established in 1823, operates as a pharmaceutical company in Warsaw, Poland, producing generic drugs in areas like anti-infectives and metabolism. They manufacture active pharmaceutical ingredients and dietary supplements using multiple production lines. The company serves public healthcare systems, doctors, patients, and wholesalers through contract manufacturing and international exports, focusing on quality and innovation.
Polfa Tarchomin's top competitors include AmerisourceBergen, NEUCA and Pelion.
Polfa Tarchomin offers Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and 2 more products and services.
Polfa Tarchomin operates through Tarchomińskie Zakłady Farmaceutyczne "Polfa" Spółka Akcyjna.